Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Multiple Myeloma 121Neoplasms, Plasma Cell 36Neoplasms 14Carcinoma, Hepatocellular 13Recurrence 12Brain Neoplasms 12Prostatic Neoplasms 11Melanoma 11Central Nervous System Neoplasms 11Glioblastoma 10Leukemia 9Carcinoma, Non-Small-Cell Lung 9Leukemia, Lymphocytic, Chronic, B-Cell 8Gliosarcoma 8Waldenstrom Macroglobulinemia 7Sarcoma 7Lung Neoplasms 7Glioma 7Colorectal Neoplasms 7Carcinoma, Renal Cell 7Myeloproliferative Disorders 5Myelodysplastic Syndromes 5Lymphoma, Mantle-Cell 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma 5Liver Neoplasms 5Kidney Neoplasms 5Immunoglobulin Light-chain Amyloidosis 5Myelodysplastic-Myeloproliferative Diseases 4Lymphoma, Follicular 4

Interventions

Bevacizumab 4Temozolomide 3Irinotecan 3Sorafenib 2Radiosurgery 2pembrolizumab 1ibrutinib 1Vorinostat 1Valproic Acid 1Transcranial Magnetic Stimulation 1Therapeutics 1Thalidomide 1Standard of Care 1Sildenafil Citrate 1Radiotherapy 1Pliability 1Plasma Exchange 1Palliative Care 1Nivolumab 1Morphine 1Methadone 1Lenalidomide 1Immunoglobulins 1Exercise 1Equipment and Supplies 1Clomipramine 1Carboplatin 1Bendamustine Hydrochloride 1Atorvastatin 1Amifampridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neurologic Manifestations × Thalidomide × Clear all
NCT00251797 2010-01-07

A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors

University of New Mexico

Phase 1 Completed
10 enrolled
CNS

Brain Neoplasms, Neoplasms, Neurologic Manifestations, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡